StÃ¤ubli Robotics to Exhibit at SLAS 2012 San Diego, CA, February 4-8, Boo bi13281867 The First Annual SLAS Conference and Exhibition, combining ?the best of the former LabAutomation and SBS conferences,? take place February 4 - 8 at the San Diego Convention Center, offering the opportunity to see emerging laboratory technologies firsthand

Pharmaceutical business boosts Cardinal Health 2Q profit - Bizjournals.com bi13281867 business boosts Cardinal Health 2Q profitBizjournals.comCardinal Health Inc. increased profit by 22 percent fiscal second quarter driven by a segment that more than made up for higher costs medical business. The Dublin-based company told investors on Thursday that earned Cardinal Health 2Q Net Up 22% On Unit StrengthFox BusinessCardinal Health profit up 22%, lifts outlookMarketWatchCardinal Health 2nd-quarter profit rises 22 percent on bigger profit from The RepublicNASDAQ -Reuters -LocalizedUSAall 28 news articles »..

Is AstraZeneca a sign of wider pharmaceutical woes? - BBC News bi13281867 USA TODAYIs AstraZeneca a sign of wider woes?BBC NewsBy James Gallagher Health and science reporter, BBC News The announcement by the drug maker AstraZeneca that cut another 7300 jobs the latest warning about the health of the industry. There are large profits being made, AstraZeneca to cut 7300 jobs as outlook darkensUSA TODAYAstraZeneca to axe 7300 jobs despite £8.4bn annual profitMetroDrugs Firm AstraZeneca To Cut 7300 JobsSky NewsManufacturer.com -Montreal Gazette -Daily Mailall 553 news articles »..

Arena Pharmaceuticals Receives Notice from FDA of Advisory Committee Meeting bi13281867 Arena s Receives Notice from FDA of Advisory Committee Meeting Sacramento Bee1, 2012 -- /PRNewswire/ -- Arena s, Inc. (NASDAQ: ARNA) and Eisai Inc. announced today that the US Food and Drug Administration (FDA) has notified Arena that an Endocrinologic and Metabolic Drugs Advisory Committee meeting to discuss the FDA panel to discuss Arena obesity drug 2nd quarterReutersall 20 news articles »..

YouTube Interview Now Available for Kedem Pharmaceuticals CEO Dr. Hassan bi13281867 YouTube Interview Now Available for Kedem s CEO Dr. Hassan MarketWatch (press release)PHOENIX, AZ, Feb 02, 2012 (MARKETWIRE via COMTEX) -- Kedem s Inc. /quotes/zigman/7221843 KDMP +19.00% , a specialty company focus on sublingual drug delivery, pleased to announce the company CEO Dr. Hassan Salari and more »..

OctoPlus enters drug development and manufacturing contract Ferring bi13281867 OctoPlus enters drug development and manufacturing contract Ferring ReutersAt OctoPlus we provide formulation development and clinical material manufacturing services to biotech and companies worldwide. In addition to our expertise formulation and manufacturing, we offer our clients drug delivery and more »..

Lilly Alzheimer's drug an unlikely ace the hole - Reuters bi13281867 International Business TimesLilly Alzheimer's drug an unlikely ace the holeReutersLilly shares have risen 13 percent the past year, compared an 8 percent rise for the ARCA Index of large drugmakers. Many investors hold the stock for hefty dividend, the company has pledged to preserve coming years Lilly Has Earned Its Lousy RepSeeking Alpha Industry Earnings 4Q: Pfizer, Eli Lilly Hit Hard, Merck NextInternational Business Timesall 13 news articles »..

Research and Markets: India Pharmaceuticals and Healthcare Report Q1 2012 - S bi13281867 Research and Markets: India s and Healthcare Report Q1 2012SunHerald.comIndia's market increasingly attract foreign drugmakers. The government has made a clear statement that values the contribution of multinationals to the overall economy. BMI believes firms should engage local producers, and more »..

Savient Pharmaceuticals Appoints David Y. Norton Interim Chief Executive Offi bi13281867 Savient s Appoints David Y. Norton Interim Chief Executive OfficerMarketWatch (press release)1, 2012 /PRNewswire via COMTEX/ -- Savient s, Inc. /quotes/zigman/90527/quotes/nls/svnt SVNT -10.67% today announced that the Company's Board of Directors has appointed David Y. Norton, a member of the Savient Board and former Company and more »..

Cytomedix Announces Option Extension With Top 20 Global Pharmaceutical Compan bi13281867 Cytomedix Announces Option Extension With Top 20 Global Company MarketWatch (press release)GAITHERSBURG, MD, Feb 02, 2012 (MARKETWIRE via COMTEX) -- Cytomedix, Inc. /quotes/zigman/3795200 CMXI -12.41% (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, and more »..

Leading Pharmaceutical Marketing Research and Consulting Company Introduces . bi13281867 Leading Marketing Research and Consulting Company Introduces MarketWatch (press release)1, 2012 /PRNewswire via COMTEX/ -- Evolution Marketing Research, the next generation marketing research and consulting company, announced that has proactively restructured order to better take advantage of the evolving global and more »..

Princeton pharmaceutical developer, Soligenix tries to up stock price - The T bi13281867 Princeton developer, Soligenix tries to up stock priceThe Times of Trenton - NJ.comBy Joshua Rosenau/Times of Trenton PRINCETON TOWNSHIP ? Local developer Soligenix sought yesterday to shore up stock price by doing a 1 for 20 reverse split, effectively converting 20 shares 1, ending at yesterday's market ..

Ps2 Backup Software - Home